Bicycle Therapeutics plc (BCYC)

Bicycle Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 23, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	482	967	767	879	1,790	382
Market Cap Growth	-63.65%	26.03%	-12.72%	-50.89%	367.95%	126.52%
Enterprise Value	-161	87	241	561	1,563	248
Last Close Price	7.19	14.00	18.08	29.60	60.87	17.95
PS Ratio	17.56	27.40	28.43	60.76	152.99	36.81
PB Ratio	0.81	1.22	2.07	3.25	5.17	4.01
P/TBV Ratio	0.78	1.22	2.07	3.25	5.17	4.01
EV/Sales Ratio	-	2.46	8.92	38.82	133.63	23.90
Debt / Equity Ratio	0.01	0.01	0.12	0.16	0.13	0.17
Asset Turnover	0.03	0.05	0.05	0.03	0.04	0.08
Quick Ratio	10.33	13.61	7.92	6.76	12.43	6.51
Current Ratio	10.66	13.81	8.08	6.93	12.65	6.73
Return on Equity (ROE)	-34.59%	-29.04%	-56.31%	-36.54%	-30.25%	-54.08%
Return on Assets (ROA)	-20.59%	-16.90%	-23.60%	-16.38%	-12.80%	-23.94%
Return on Capital (ROIC)	-24.72%	-21.53%	-32.48%	-20.66%	-16.35%	-31.48%
Return on Capital Employed (ROCE)	-41.70%	-23.60%	-36.10%	-32.70%	-14.80%	-37.60%
Earnings Yield	-52.07%	-17.49%	-23.55%	-12.83%	-3.73%	-13.34%
FCF Yield	-50.24%	-17.17%	-8.29%	-11.96%	-0.94%	-4.96%
Buyback Yield / Dilution	-34.28%	-63.54%	-20.00%	-18.35%	-30.90%	-73.34%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q